Experimental and clinical evidence supports the use of urokinase plasminogen activation system components as clinically relevant biomarkers in gastroesophageal adenocarcinoma
- Gary Tincknell
- , Ann-Katrin Piper
- , Morteza Aghmesheh
- , Therese Becker
- , Kara Lea Vine
- , Daniel Brungs
- , Marie Ranson
Research output: Contribution to journal › Article › peer-review
11
Citations
(Scopus)
3
Downloads
(Pure)